Checkpoint Trends
85.00
-4.45(-4.97%)
Market Cap₹46.47 Cr
PE Ratio23.92
IndustryHealthcare
Company Performance:
1D-4.97%
1M-34.16%
6M+119.58%
1Y+464.78%
5Y+1,700.85%
View Company Insightsright
More news about Checkpoint Trends
12Nov 25
Checkpoint Trends Limited Reports Significant Revenue Growth in Q2 FY2026
Checkpoint Trends Limited, operating in Tobacco and FMCG sectors, reported substantial revenue increase for Q2 FY2026. Net sales reached ₹10,859.42 lakhs, with total H1 FY2026 revenue at ₹12,030.69 lakhs. Profit for Q2 stood at ₹132.14 lakhs. FMCG segment led with ₹7,292.32 lakhs revenue, while Tobacco Products contributed ₹3,567.10 lakhs. Balance sheet showed significant increases in trade receivables and payables. The company's trading window for designated persons will reopen from November 15, 2025.
 no imag found
28Oct 25
Checkpoint Trends Limited Shareholders Approve Rs 500 Crore QIP and Convertible Warrants Issuance
Checkpoint Trends Limited (BSE: 531099) held an EGM on October 27, 2025, where shareholders approved two key resolutions with 99.99% votes in favor. The first resolution allows the issuance of convertible warrants on a preferential basis. The second authorizes raising up to Rs 500 crore through a Qualified Institutions Placement (QIP). The virtual meeting was attended by 41 members, including 7 from the promoter/director/KMP category and 34 from the public. E-voting was conducted from October 24 to October 26, 2025.
 no imag found
16Oct 25
Checkpoint Trends Limited Modifies Fundraising Plans in EGM Notice Corrigendum
Checkpoint Trends Limited has issued a corrigendum to its EGM notice, modifying its fundraising plans. The company now aims to raise Rs. 170 crores through preferential issue of convertible warrants and Rs. 500 crores via Qualified Institutions Placement (QIP). Funds will be used for buyout of Global Tabbac Legacy, working capital, and general corporate purposes. The entire proceeds are expected to be utilized within 12 months, with Acuite Ratings & Research Limited appointed as the monitoring agency. The corrigendum lists 14 non-promoter allottees for the warrant issue and adjusts a price reference from Rs. 40.01 to Rs. 45.01. The Board retains discretion to reallocate funds within a +/- 10% deviation.
 no imag found
24Sept 25
Checkpoint Trends Limited Unveils Rs. 670 Crore Fundraising Plan Through Convertible Warrants and QIP
Checkpoint Trends Limited (BSE: 531099) has announced plans to raise Rs. 670 crore through two initiatives. The company will issue convertible warrants worth Rs. 170 crore to non-promoter entities and equity shares via Qualified Institutions Placement (QIP) for up to Rs. 500 crore. The convertible warrants issuance includes approximately 3,84,61,539 warrants, each convertible into one equity share within 18 months. Notable allottees include Pandokhar Food LLP, Lemon Electronics Limited, and Recoll Projects Private Limited. The fundraising proposals are subject to shareholder and regulatory approvals, with an Extraordinary General Meeting planned to seek shareholder approval.
 no imag found
22Sept 25
Checkpoint Trends Limited Shareholders Overwhelmingly Approve Capital Increase and Memorandum Amendments
Checkpoint Trends Limited successfully concluded a postal ballot process with shareholders overwhelmingly approving two crucial resolutions. The first resolution, to increase authorized share capital and alter the Memorandum of Association's capital clause, and the second, to add to the Object Clause of the Memorandum of Association, both passed with 99.93% votes in favor. The e-voting process, facilitated by CDSL, saw participation from 83 out of 2,459 shareholders. These approvals potentially provide the company with greater financial flexibility and opportunities for business expansion.
 no imag found
19Sept 25
Checkpoint Trends Limited to Reassess Fund-Raising Plans in Upcoming Board Meeting
Checkpoint Trends Limited (BSE: 531099) has scheduled a board meeting for September 24, 2025, to reassess fund-raising decisions made on September 10, 2025. The board will evaluate revised proposals for capital raising through preferential allotment, convertible warrants, Qualified Institutional Placement (QIP), and other permissible instruments. The company will also reconsider the date for its Extra-ordinary General Meeting, initially set for October 13, 2025. This development has been communicated to BSE Limited in compliance with SEBI regulations.
 no imag found
16Sept 25
Checkpoint Trends Limited Announces CFO Transition: Abha Kapoor Resigns, Shubham Chaudhary Takes the Helm
Checkpoint Trends has announced changes in its top finance leadership. Ms. Abha Rajesh Kapoor has resigned as Whole-Time Director and Chief Financial Officer, effective September 16, 2025, citing personal reasons. Mr. Shubham Chaudhary, currently a Whole-Time Director, will take over as the new Chief Financial Officer effective September 17, 2025. Mr. Chaudhary brings over eight years of experience in marketing, sales strategies, and team leadership.
 no imag found
18Aug 25
Checkpoint Trends Limited Plans Fourfold Increase in Authorized Share Capital, Diversifies into Tobacco and Edible Oils
Checkpoint Trends Limited (BSE: 531099) has announced significant changes to its corporate structure and business focus. The company plans to increase its authorized share capital from Rs. 75.00 crores to Rs. 300.00 crores, expanding equity shares from 7.50 crore to 30.00 crore. The company also aims to diversify into tobacco-related trading and the edible oils business. These changes are subject to shareholder approval through a postal ballot process with e-voting scheduled from August 21 to September 20, 2025. The company views these moves as strategic steps to optimize resources, enhance efficiency, and create sustainable value for stakeholders.
 no imag found
Checkpoint Trends
85.00
-4.45
(-4.97%)
1 Year Returns:+464.78%
Industry Peers
Sun Pharmaceutical
1,724.40
(+0.64%)
Divis Laboratories
6,291.00
(-0.10%)
Torrent Pharmaceuticals
4,241.70
(+0.36%)
Cipla
1,341.10
(+0.92%)
Dr Reddys Laboratories
1,280.40
(-0.15%)
Lupin
2,219.40
(-0.42%)
Zydus Life Science
900.75
(-0.18%)
Mankind Pharma
2,024.30
(-0.75%)
Aurobindo Pharma
1,158.80
(-1.08%)
Alkem Laboratories
5,392.00
(+0.28%)